Skowron, Piotr M. https://orcid.org/0000-0003-1345-3271
Krefft, Daria
Brodzik, Robert
Kasperkiewicz, Paulina
Drag, Marcin
Koller, Klaus-Peter
Funding for this research was provided by:
Barentzymes AS, Norway (company funds)
Article History
Received: 7 March 2020
Accepted: 15 June 2020
First Online: 24 June 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: None declared. The recombinant NHSSP variants and their applications are owned by Barentzymes AS (Norway) and has been protected by EU patent application A2362DG-EP [], that are currently being processed.